Search
Now showing items 1-5 of 5
Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial.
(2015-03)
Background: Bevacizumab (Avastin®) is as effective as ranibizumab (Lucentis®) in the treatment of neovascular age-related macular degeneration (nAMD). However it has two important structural differences. First, it has two ...
The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: A comparison with fundus fluorescein angiography.
(2015-05)
Purpose: To evaluate the diagnostic accuracy of spectral-domain optical coherence tomography (SD-OCT) for neovascular age-related macular degeneration (nAMD): a comparison against fundus fluorescein angiography (FFA).
Methods: ...
Computer vision syndrome-A common cause of unexplained visual symptoms in the modern era.
(2017-07)
Objectives: The aim of this study was to assess the evidence and available literature on the clinical, pathogenetic, prognostic and therapeutic aspects of Computer vision syndrome.Methods: Information was collected from ...
Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy.
(2016-06)
Purpose To report the association and prevalence of reticular pseudodrusen (RPD) in eyes with newly presenting adult onset foveomacular vitelliform dystrophy (AFVD). To compare the strength of association with other ...
Prevalence of reticular pseudodrusen in eyes with newly presenting neovascular age-related macular degeneration.
(2016-03)
Purpose: To use multimodal imaging to evaluate the prevalence of reticular pseudodrusen (RPD) in eyes with newly presenting neovascular age-related macular degeneration (nAMD) in a UK population and explore associations ...